Gmail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
  
Discussions for 3SBio Inc. View all discussions

  SSRX Due Diligence Page
All 5 messages in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
jonathanwsto...@gmail.com  
View profile  
(1 user)  More options Feb 16 2007, 12:38 pm
From: jonathanwsto...@gmail.com
Date: Fri, 16 Feb 2007 17:38:58 -0000
Local: Fri, Feb 16 2007 12:38 pm
Subject: SSRX Due Diligence Page
The best SSRX due diligence I have found is http://www.valuewiki.com/w/
SSRX

I checked yahoo finance, raging bull, ihub, and investorvillage, and
none of them have SSRX message boards yet.  Only at ValueWiki is there
already a message board, chat room, and a lot of due diligence.


    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
Jonah Weiss  
View profile  
 More options Mar 1 2007, 2:59 pm
From: "Jonah Weiss" <weiss.jo...@gmail.com>
Date: Thu, 01 Mar 2007 11:59:06 -0800
Local: Thurs, Mar 1 2007 2:59 pm
Subject: Re: SSRX Due Diligence Page
Is the recent drop in the price of SSRX based on the recent safety
concerns of AMGEN's EPO drugs?

    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
dad.mitch...@gmail.com  
View profile  
 More options Mar 1 2007, 4:23 pm
From: dad.mitch...@gmail.com
Date: Thu, 01 Mar 2007 21:23:27 -0000
Local: Thurs, Mar 1 2007 4:23 pm
Subject: Re: SSRX Due Diligence Page
what is down with this ipo

    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
jol...@gmail.com  
View profile  
(1 user)  More options Mar 5 2007, 2:13 pm
From: jol...@gmail.com
Date: Mon, 05 Mar 2007 11:13:11 -0800
Local: Mon, Mar 5 2007 2:13 pm
Subject: Re: SSRX Due Diligence Page
Not really.

Income growth is deemed to be acceptable but not explosive at the
beginning. Remember that an important portion of the IPO proceeeds are
intended for clinical trials, so those of us who would like to see
short term positive pull would be much better rewarded if we have
patiency. The lows the stock is showing after the recent market slump
are not concerning as the trading volume is really very low.

Jonah Weiss wrote: Is the recent drop in the price of SSRX based on

the recent safety concerns of AMGEN's EPO drugs?

    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
weijia780...@yahoo.com  
View profile  
 More options Mar 9 2007, 2:25 pm
From: weijia780...@yahoo.com
Date: Fri, 09 Mar 2007 11:25:09 -0800
Local: Fri, Mar 9 2007 2:25 pm
Subject: Re: SSRX Due Diligence Page
I think at this level, SSRX is a good buy

    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  Financials look VERY STRONG!   No older discussions




Google Home - Terms of Service - Privacy Policy

©2010 Google